NCT00049699View on ClinicalTrials.gov

VNP40101M in Treating Patients With Advanced or Metastatic Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2002

Study Completion Date

January 31, 2008

Conditions
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

laromustine

Trial Locations (3)

06520-8028

Yale Comprehensive Cancer Center, New Haven

06516

Veterans Affairs Medical Center - West Haven, West Haven

44106-5065

Ireland Cancer Center, Cleveland

Sponsors
All Listed Sponsors
lead

Vion Pharmaceuticals

INDUSTRY

NCT00049699 - VNP40101M in Treating Patients With Advanced or Metastatic Cancer | Biotech Hunter | Biotech Hunter